Novo Nordisk A/S Share Repurchase Programme Update

Novo Nordisk A/S initiated a share repurchase program on February 4, 2026, in accordance with MAR and the Safe Harbour Rules. This program is part of a larger initiative to repurchase up to DKK 15 billion worth of shares over a 12-month period. Specifically, within the timeframe of February 4, 2026, to May 4, 2026, Novo Nordisk has repurchased B shares valued up to DKK 3.8 billion. As of April 17, 2026, the company has bought back 12,257,992 B shares at an average price of DKK 256.87 per share, totaling DKK 3,148,710,807. Following these transactions, Novo Nordisk holds 28,397,791 B shares as treasury shares, representing 0.6% of the total share capital. The company expects to complete the DKK 15 billion repurchase program within the 12-month period starting February 4, 2026.